BACKGROUND
Quality control (QC) policies are usually designed using power curves. This type of analysis reasons from a cause (a shift in the assay results) to an effect (a signal from the QC monitoring process). End users face a different problem: they must reason from an effect (QC signal) to a cause. It would be helpful to have metrics that evaluated QC policies from an end-user perspective.
METHODS
We developed a simple dichotomous model based on classification of assay errors. Errors are classified as important or unimportant based on a critical shift size, defined as Sc. Using this scheme, we show how QC policies can be analyzed using common accuracy metrics such as sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). We explore the impact of design choices (QC limits, number of repeats) on these performance measures in a number of different contexts.
RESULTS
PPV varies widely (1% to 100%) depending on context. NPV also varies (40% to 100%) but is less sensitive to context than PPV. There are many contexts in which QC policies have low predictive values. In such cases, performance (PPV, NPV) can be improved by adjusting the QC limits or the number of repeats at each QC event.
CONCLUSION
The effectiveness of QC can be improved by considering the context in which the QC policy will be applied. Using simple assumptions, common accuracy metrics can be used to evaluate QC policy performance.
[1]
J O Westgard,et al.
Power functions for statistical control rules.
,
1979,
Clinical chemistry.
[2]
Fred Spiring,et al.
Introduction to Statistical Quality Control
,
2007,
Technometrics.
[3]
Curtis A Parvin,et al.
Should I repeat my 1:2s QC rejection?
,
2012,
Clinical chemistry.
[4]
J O Westgard,et al.
Selection of medically useful quality-control procedures for individual tests done in a multitest analytical system.
,
1990,
Clinical chemistry.
[5]
J O Westgard,et al.
A predictive value model for quality control: effects of the prevalence of errors on the performance of control procedures.
,
1983,
American journal of clinical pathology.
[6]
S. Westgard,et al.
Assessing precision, bias and sigma-metrics of 53 measurands of the Alinity ci system.
,
2017,
Clinical biochemistry.